G.29.505 was used as a single dose induction agent (4 mg/kg) before nitrous oxide and oxygen with halothane or trichloroethylene for the operation of dilatation and curettage. The findings are compared with those of another series in which intermittent injections of G.29.505 supplemented the nitrous oxide. Rapid recovery resulted in a high incidence of coughing and hiccough during the introduction of both volatile agents. Hyoscine premedication increased the frequency of spontaneous muscle movements following the induction of anaesthesia. Halothane was followed by a very low incidence of emetic sequelae. G.29.505 cannot be used as a satisfactory substitute for an induction dose of thiopentone.
A recent study by the authors (Dundee and Rajagopalan, 1962) compared the effects of thiopentone and G.29.505 as main narcotic agents for a standard operation and found that both were equally satisfactory after the anaesthetist had become experienced in the use of the latter drug. G.29.505 was found to have certain advantages over thiopentone, of which the most important were the virtual absence of arterial hypotension and the rapidity of return of consciousness. For this reason it was thought to warrant further study, particularly when used solely as an induction agent, and with a variety of premedications. Data obtained using a drug as the sole potent anaesthetic with nitrous oxide and oxygen mixtures are valuable in establishing the basic actions of the drug. These data, however, may be of limited value in predicting its ultimate place in anaesthetic practice.
PRESENT STUDY
This paper reports a study in which G.29.505 was used in a fixed dosage of approximately 4 mg/kg to induce anaesthesia, and was followed by nitrous oxide and oxygen with a volatile anaesthetic agent. The choice of patients, the nature of the operations, and the observations made during and after anaesthesia were identical with those in the previous study (Dundee and Rajagopalan, 1962) . The supplementary agents were volatilized in the stan-19 dard chloroform bottle of the Boyle apparatus and the concentrations used were determined entirely by the clinical judgment of the anaesthetist. Since this may vary from patient to patient, changes in blood pressure during anaesthesia and the state of wakefulness 2 minutes after the end of the operation are not reported. Each series was composed of equal numbers of patients having cervical dilatation and uterine curettage, or curettage without preliminary dilatation, and it is thus justifiable to compare the frequency of emetic symptoms with the various combinations used (Dundee, Nicholl and Moore, 1962) . Premedication consisted of atropine 0.6 mg, hyoscine 0.4 mg, or pethidine 100 mg with atropine 0.6 mg. Halothane and trichloroethylene were the volatile agents used since they are most generally employed for the operations used in this study. Data from the previous study (G.29.505 followed by nitrous oxide and oxygen alone; atropine premedication) is included for the sake of comparison.
It is regretted that the incidence of thrombosis limited each series to fifty cases, even though the emulsion form of G.29.505 was used throughout.
RESULTS
The course of anaesthesia in each series is summarized in table I, which shows that the findings are based on fairly comparable groups of patients.
The most striking finding was that the use of either volatile supplement increased the incidence of respiratory upset during anaesthesia, except in patients premedicated with an opiate (table II) . There was no difference in the incidence with trichloroethylene and halothane, when the premedication was kept constant. The pre-operative use of hyoscine reduced the incidence in one series (trichloroethylene), but not when halothane was used.
The incidence of excitatory phenomena was very similar in all series, except those which received hyoscine premedication. The increase in incidence with hyoscine as compared with atropine, reached the 0.1 per cent level of significance with both volatile supplements.
Except in cases premedicated with pethidine and atropine, it can be seen from the distribution of the grades of anaesthesia (table I) that the use of G.29.505 solely as an induction agent, followed by volatile supplements, did not result in smooth anaesthesia as frequently as was the case when the intermittent injection technique was used. This is also true when grades 1 and 2a are pooled as representing satisfactory anaesthesia. Premedication with hyoscine markedly reduced the incidence of completely uneventful administrations (grade 1), due to the frequency of excitatory phenomena associated with its use. It did not, however, significantly increase the incidence of complications of such severity as to influence the course of anaesthesia (grade 2b) with either halothane or trichloroethylene. This shows that the involuntary muscle movements were not very severe.
EMETIC SEQUELAE
The incidence of postoperative emetic symptoms was not followed up completely in the series in which halothane was used, after hyoscine premedication. The incidence of symptoms during the first 6 hours after anaesthesia in the other groups is shown in table III. All the differences which reached the 5 per cent level of significance occurred during the first postoperative hour. In patients premedicated with atropine, the lowest incidence occurred after the use of halothane and the number of patients having no emetic symptoms differed significantly from the group of patients who received trichloroethylene (x 2 = 13.0710; P<0.001) and those who received no volatile supplements (x 2 = 14.5107; P<0.001). Nausea accounted for part of the increase in symptoms with trichloroethylene, and its incidence was similar after atropine and hyoscine premedication. The addition of pethidine to the premedication significantly increased the incidence of emetic symptoms after halothane (x 2 = 13.0710; P<0.001), but in this instance it was the frequency of vomiting which was increased.
A better comparison of the overall picture of severity of emetic symptoms in the different series is obtained by using the scoring scheme described by Dundee, Nicholl and Moore (1962) and ridit analysis. This scheme grades symptoms into eight groups according to their significance from the point of view of safety and degree of upset to the patient; for example early vomiting (0-1 hour) is more dangerous than late (1-6 hours) vomiting, while late nausea causes more upset than early nausea. Figure 1 confirms that not only did the atropine, G.29.505, halothane series of patients have the lowest incidence of emetic symptoms, but that the severity of sickness was also less in this group, and was greatest in those patients premedicated with an opiate. It also demonstrates that although hyoscine premedication did not reduce the frequency of emetic symptoms, it lessened their severity.
DISCUSSION
The higher incidence of respiratory upset found when nitrous oxide and oxygen was supplemented by volatile anaesthetic agents is accounted for by the rapid recovery from the induction dose of G.29.505 used in this study. Only an inadequate amount of the supplementary agent could be introduced during the initial phase of hyperventilation. The slow onset of action of trichloroethylene, as compared with halothane, was very noticeable during the investigation. The concentration of the latter was kept low lest hypotension should occur after the period of increased tidal volume and the overall effect of anaesthesia with both agents was very similar (table I) .
The findings emphasize those of a previous study (Dundee and Rajagopalan, 1962) which stated that G.29.505 must not be considered simply as a substitute for thiopentone. The induction dose of 4 mg/kg is probably too small for routine use, but prolonged apnoea may result from a higher dosage. (It was necessary to use it in this study so 1 Ridit analysis of postoperative emetic symptoms, graded by scoring system referred to in text. Graph shows mean ridit and 95 per cent confidence levels of mean.
In upper part of the diagram the pooled total cases are taken as the identified distribution, and each individual series compared with total.
In lower part only the patients premedicated with atropine 0.6 mg are studied and the group receiving no volatile supplements is the identified distribution.
The rectangle indicating the SE of the average ridit is divided into two to identify series.
that the results could be compared with those obtained from the series of 100 patients to which the drug was given by intermittent administration.) If it is decided that G.29.505 be used for induction of anaesthesia with a balanced technique, it is advisable to leave the needle in the vein and to inject supplementary doses of 1-2 mg/kg as required until anaesthesia has been established by the agents chosen for maintenance. The experience of many workers suggests that this can be done with less fear of the sequelae of hypotension, respiratory arrest and delayed recovery than if thiopentone is used. It must be remembered that each supplementary dose of G.29.505 will result in transient hyperventilation which may increase the uptake of gaseous and volatile agents.
It is interesting to note that the pre-operative use of hyoscine increased the incidence of excitatory phenomena which followed a constant dose of G.29.505. This has been shown to occur with methohexitone (Dundee and Moore, 1961; Dundee et al.j 1961) and is probably due to the antanalgesic action of this form of premedication (Dundee and Moore, 1961) . On the other hand, the use of an analgesic (pethidine) did not reduce the incidence of this complication.
The low incidence of emetic symptoms when halothane was used for maintenance of anaesthesia (after atropine premedication) as compared with trichloroethylene is surprising. Recovery of consciousness was more rapid after halothane than following trichloroethylene and this shows that there are factors influencing the emetic sequelae of anaesthesia other than early mobility of the patients. While it appears fundamentally wrong to ascribe anti-emetic properties to a volatile anaesthetic, the findings of this study support those of Novoa (1960) . The increase in emetic symptoms following opiate premedication (table III) agrees with the results of Riding (1961) who used thiopentone as sole anaesthetic for the same operation as in this investigation. SOMMAIRE Le G.29.505 fut employe comme produit d'induction a une seule dose (4 mg/kg) avant l'oxyde nitreux et Foxygene avec halothane ou trichlorethylene -dans Fintervention-standard de dilatation aux fins de curettage. Les constatations faites a l'emploi furent compare'es avec celles d'une autre serie dans laquelle des injections intermittentes de G.29.505 servirent de complement a l'administration d'oxyde nitreux. Le retablissement des patients 6tait rapide mais entraina un pourcentage eleve de quintes de toux et de hoquet pendant l'introduction des deux agents volatiles. Le traitement prealable par Fhyoscine augmenta la frequence des mouvements musculaires spontanes apres induction de Fanesthesie. Le Halothane ne provoqua que tres peu de vomissements consecutifs. Le G.29.505 ne peut pas etre utilise' comme produit de substitution satisfaisant pour une dose d'introduction de thiopentone. ZUSAMMENFASSUNG G.29.505 wurde als 1-Dosis-Praparat zur Narkose einleitung (4 mg/kg) vor Lachgas und Sauerstoff mit Halothan oder Trichlorathylen fur den operativen Eingriff einer Dilatierung und Curettage gegeben. Die Ergebnisse werden mit denen einer anderen Untersuchungsreihe verglichen, bei der intermittierende Injektionen von G.29.505 das Lachgas erganzten. Bei rascher Erholungsphase kam es wa'hrend der Zufuhr der beiden fltichtigen Praparate sehr haufig zu Husten und Singultus. Eine Pramedikation mit Hyoscin erhohte die Haufigkeit spontaner Muskelbewegungen nach Einleitung der Narkose. Emetische Folgeerscheinungen waren nach Halothan sehr gering. G.29.505 kann eine einleitende Dosis Thiopenton nicht ersetzen.
